McKinsey

SEPTEMBER 17, 2022

The sometimes-overlooked function of chemistry, manufacturing, and controls (CMC) has a rare opportunity to reimagine its role and find innovative ways to improve and accelerate drug development.

Shadowing 93

Shadowing Development Manufacturing IT 93

McKinsey

MAY 13, 2021

A review of the funding, operational, technological, and regulatory factors that allowed for fast development of COVID-19 vaccines shows which will remain relevant for future efforts—and which won’t.

Development 132

Development Medical Pharmaceutical 132

McKinsey

OCTOBER 23, 2020

Two experts discuss how quantum computing can help solve intractable problems in drug discovery and development.

Development 135

Development Medical Pharmaceutical 135

McKinsey

AUGUST 27, 2020

The COVID-19 crisis is exacerbating what is considered a critical vulnerability in the health infrastructure of many developing countries—a severe shortage of medical oxygen.

Development 128

Development Medical Pharmaceutical 128

McKinsey

JULY 31, 2018

By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry.

Pharmaceutical 61

Pharmaceutical Development Medical 61

McKinsey

NOVEMBER 2, 2019

Innovations in biomedical sciences and technology fuel the opportunity to transform R&D for new-drug development holistically—500 days faster, better tailored to patient needs, and 25 percent cheaper.

Development 47

Development Medical Pharmaceutical 47

Harvard Professional Development

FEBRUARY 25, 2022

Innovation and Educational Research, Director, Vertex Pharmaceuticals, Inc. For much of my career, I contributed to pharmaceutical and biotech drug discovery as a scientist, team leader, and scientific program manager. How has the program helped your career development? Explore all Professional Development Programs.

Creativity 52

Creativity Creative Thinking Pharmaceutical Divergent Thinking 52

McKinsey

JULY 25, 2018

The potential for real-world evidence is expanding, particularly in oncology drug development. To compete, some companies are investing in robust real-world data and analytic capabilities.

Development 62

Development Medical Pharmaceutical 62

Strategy+Business

MAY 11, 2014

Looking toward the future, pharmaceutical companies and other stakeholders will adopt existing technologies and develop new ones, creating a more connected digital healthcare ecosystem.' Doctors and patients are starting to use digital tools to manage healthcare more efficiently.

Healthcare 57

Healthcare Pharmaceutical Development Management 57

McKinsey

OCTOBER 13, 2018

In a sector undergoing unprecedented change, five muscles will define the successful leaders of the future.

Development 88

Development Medical Pharmaceutical 88

StrategyU

NOVEMBER 17, 2023

hot” areas include data analytics, digital marketing, and pharmaceuticals. If training is something you can deprioritize, your firm will struggle with developing internal capabilities. The training was vital to the success of the firm, and everyone treated it as such. Do you have a toolkit for business problem solving?

Consulting 40

Consulting Business Problem Solving Pharmaceutical Strategy 40

On The Job

OCTOBER 3, 2012

That means interns are put through a program that exposes them to a wide variety of experiences at the pharmaceutical and health care company so they can be evaluated for their skills. Our internship program is a core component of our talent pipeline strategy," she says. It's a way to identify our future leaders."

Pharmaceutical 218

Pharmaceutical Networking Career Development Media 218

McKinsey

APRIL 15, 2022

Health data platforms that participants trust could bring an end to today’s reductionist approach to drug development, revolutionizing our understanding of disease.

Development 116

Development Pharmaceutical 116

McKinsey

AUGUST 15, 2022

China-originated biopharmas will likely have greater influence on the industry by 2028, but regulatory developments and the quality of partnerships will determine how the industry grows.

Development 92

Development Pharmaceutical 92

Gordian Business

JULY 23, 2019

A pharmaceutical company asked for help to implement its SAM program. They had spent many months developing policies and procedures and templates for SAM processes, yet had not started anything with their team or customers. They planned to roll out their SAM program in a couple of years.

Accounting 52

Accounting Management Management Pharmaceutical 52

McKinsey

MAY 12, 2021

The leaders of Gingko Bioworks and the BIO organization discuss the future of biological technologies, from developing vaccines faster to changing how we produce food.

Food 113

Food Development Medical Pharmaceutical 113

McKinsey

JULY 24, 2020

How quickly COVID-19 vaccine production ramps up will depend on technology transfer—the capabilities and processes that can speed vaccines from development to manufacturing. Are we ready?

Manufacturing 129

Manufacturing Development Medical Pharmaceutical 129

McKinsey

MAY 17, 2021

Success depends on innovative solutions that remain under development. Viral-vector gene therapies show great promise, but the full extent of their clinical impact in the long term is not yet certain.

Solution 98

Solution Development Pharmaceutical Medical 98

McKinsey

FEBRUARY 10, 2023

Preclinical development can benefit from advances to accelerate innovation, unlock value, and improve quality.

Development 75

Development Pharmaceutical 75

McKinsey

AUGUST 17, 2022

The cochairman and managing director of the pharma multinational believes India’s competence in new biology, clinical development, and chemistry will increase its global competitiveness.

Development 75

Development Management Management IT 75

McKinsey

JULY 30, 2020

Innovators are sprinting to develop inoculations against the novel coronavirus. Here, we summarize the latest information on research timelines and the potential impact of a vaccine on the pandemic—and society.

Development 110

Development Medical Pharmaceutical 110

McKinsey

MAY 13, 2021

The small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment.

Strategy 70

Strategy Development Pharmaceutical Medical 70

McKinsey

MAY 8, 2019

Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex vaccines could renew the innovation engine.

Engineering 104

Engineering Strategy Development Medical 104

Harvard Professional Development

MAY 25, 2022

Taking time away from the day-to-day demands of your job to pursue professional development can be challenging. For many of our participants, the most valuable part of the professional development experience is identifying actionable tips and strategies that they can apply immediately upon the return to the office. Mary Wells.

Professional development 52

Professional development Development Strategic Planning Design Thinking 52

McKinsey

MARCH 15, 2019

The Head of Digital Strategy and Medical Innovation, US Clinical Development and Medical Affairs at Novartis discusses how disruptive technologies and digital innovation are inspiring a start-up mind-set within the organization.

Medical 92

Medical Strategy Development Pharmaceutical 92

McKinsey

OCTOBER 1, 2019

Borrowing from the field of engineering, applying a “failure modes analysis” can quickly take some unnecessary risk out of a development program for innovative modalities.

Engineering 61

Engineering Development Medical Pharmaceutical 61

McKinsey

APRIL 2, 2019

Affordable biologic therapies could help expand patients’ access to treatment in the developing world. Here’s what pharma companies must know to unlock the potential.

Development 67

Development Medical Pharmaceutical 67

Crestcom

FEBRUARY 17, 2023

Meet Mihaela Berciu, Leadership Breakthrough Specialist Jenn DeWall: Mihaela’s client portfolio ranges from banking, financial consulting, pharmaceuticals, FMCGs, retail fashion, television, aviation services, and more. A Message from Crestcom Crestcom is a global organization dedicated to developing effective leaders.

Communication 52

Communication Leadership IT Development 52

McKinsey

OCTOBER 3, 2019

Amid breakthroughs in gene editing, the pharma industry must recalibrate its development and reimbursement model for therapies that go beyond the traditional approach to disease treatment.

Development 21

Development IT Medical Pharmaceutical 21

Crestcom

APRIL 8, 2022

Liz Kislik , a Harvard Business Review and Forbes contributor, has over 30 years of experience speciaLizing in developing high-performing leaders in workforces as a management consultant and executive coach. A Message from Crestcom: Crestcom is a global organization dedicated to developing effective leaders.

Executive Coach 98

Executive Coach Executive Coaching Strategy Leadership 98

McKinsey

SEPTEMBER 18, 2019

Europe ranks high in the level of innovation and the quality of R&D talent, particularly for research, and the amount of available talent in drug development is increasing. For rare diseases and oncology, however, experienced people are considered to be in short supply.

Development 58

Development Medical Pharmaceutical 58

Penelope Trunk

OCTOBER 29, 2009

'Saving lives' (as is the case in your example with the pharmaceutical company above etc) is the means to making a profit and not the ends of their work. There was so little opportunity for true growth or development but I kept telling myself that I should be happier being at a non-profit and not "working for the man."

Insurance 111

Insurance Government Management Management 111

McKinsey

SEPTEMBER 11, 2019

Europe has world-class universities, research institutions, medical centers, and hospitals that provide a strong base for sourcing and developing scientific innovation. However, this strength does not yet translate into patents for new medicines, as Europe trails both China and the United States in that area.

Hospitality 53

Hospitality Medical Development Pharmaceutical 53

Penelope Trunk

AUGUST 30, 2010

And pharmaceuticals have been such a disappointment to me.” In fact, I am enthralled with mixing pharmaceuticals off-label. I picked Beastie Boys and Arrested Development because I read that people who like hip-hop tend to have high self-esteem. Ryan Healy said, ‘You sure are a late-bloomer to this. And I picked Fergie for fun.

IT 110

IT Pharmaceutical Career Management 110